Clin Res Hepatol Gastroenterol 2020 Jan 25
Transient elastography for assessment of fibrosis and steatosis of liver grafts from brain-death donors.
Liu WY, Wang JH, Guo Y, Wang X, Wu XD, Xu CS, Zhao Y, Zang YJ
An objective and accurate evaluation of liver grafts is required to improve the prognosis of liver transplant recipients and to increase the number of ...
Read More
Source: PubMed
J Assoc Physicians India
Correlation of Fibroscan with FIB-4 index and APRI for Assessment of Liver Fibrosis in patients with Nonalcoholic Fatty Liver Disease.
Soni A, Tripathi BK
Read More
Source: PubMed
Lancet Gastroenterol Hepatol 2020 Jan 15
Prevalence of steatosis and fibrosis in young adults in the UK: a population-based study.
Abeysekera KWM, Fernandes GS, Hammerton G, Portal AJ, Gordon FH, Heron J, Hickman M
The estimated worldwide prevalence of non-alcoholic fatty liver disease (NAFLD) in adults is 25%; however, prevalence in young adults remains unclear. ...
Read More
Source: PubMed
Obes Surg 2020 Jan 18
Fibroscan-Based Score to Predict Significant Liver Fibrosis in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease.
Kao WY, Chang IW, Chen CL, Su CW, Fang SU, Tang JH, Chang CC, Chang YJ, Wang W
The prevalence rate of nonalcoholic fatty liver disease (NAFLD) has been reported in 74 to 90% of morbidly obese patients. This study aims to develop ...
Read More
Source: PubMed
J. Gastroenterol. Hepatol. 2020 Jan 06
Liver stiffness measurement in non-alcoholic fatty liver disease: Two is better than one.
Chuah KH, Lai LL, Vethakkan SR, Nik Mustapha NR, Mahadeva S, Chan WK
Repeating liver stiffness measurement (LSM) was recently reported to improve accuracy to diagnose fibrosis stage in patients with non-alcoholic fatty ...
Read More
Source: PubMed
Clin Res Hepatol Gastroenterol 2020 Jan 25
Transient elastography for assessment of fibrosis and steatosis of liver grafts from brain-death donors.
Liu WY, Wang JH, Guo Y, Wang X, Wu XD, Xu CS, Zhao Y, Zang YJ
An objective and accurate evaluation of liver grafts is required to improve the prognosis of liver transplant recipients and to increase the number of ...
Read More
Source: PubMed
J Assoc Physicians India
Correlation of Fibroscan with FIB-4 index and APRI for Assessment of Liver Fibrosis in patients with Nonalcoholic Fatty Liver Disease.
Soni A, Tripathi BK
Read More
Source: PubMed
Lancet Gastroenterol Hepatol 2020 Jan 15
Prevalence of steatosis and fibrosis in young adults in the UK: a population-based study.
Abeysekera KWM, Fernandes GS, Hammerton G, Portal AJ, Gordon FH, Heron J, Hickman M
The estimated worldwide prevalence of non-alcoholic fatty liver disease (NAFLD) in adults is 25%; however, prevalence in young adults remains unclear. ...
Read More
Source: PubMed
Obes Surg 2020 Jan 18
Fibroscan-Based Score to Predict Significant Liver Fibrosis in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease.
Kao WY, Chang IW, Chen CL, Su CW, Fang SU, Tang JH, Chang CC, Chang YJ, Wang W
The prevalence rate of nonalcoholic fatty liver disease (NAFLD) has been reported in 74 to 90% of morbidly obese patients. This study aims to develop ...
Read More
Source: PubMed
J. Gastroenterol. Hepatol. 2020 Jan 06
Liver stiffness measurement in non-alcoholic fatty liver disease: Two is better than one.
Chuah KH, Lai LL, Vethakkan SR, Nik Mustapha NR, Mahadeva S, Chan WK
Repeating liver stiffness measurement (LSM) was recently reported to improve accuracy to diagnose fibrosis stage in patients with non-alcoholic fatty ...
Read More
Source: PubMed
